Amie C. Shei, Ph.D. - Publications

Affiliations: 
2011 Harvard University, Cambridge, MA, United States 

10 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Shei A, Rice B, Kirson NY, Bodnar K, Enloe CJ, Birnbaum HG, Holly P, Ben-Joseph R. Characteristics of High-Cost Patients Diagnosed with Opioid Abuse. Journal of Managed Care & Specialty Pharmacy. 21: 902-12. PMID 26402390  0.777
2015 Shei A, Hirst M, Kirson NY, Enloe CJ, Birnbaum HG, Dunlop WC. Estimating the health care burden of prescription opioid abuse in five European countries. Clinicoeconomics and Outcomes Research : Ceor. 7: 477-88. PMID 26396536 DOI: 10.2147/CEOR.S85213  0.739
2015 Kirson NY, Shei A, Rice JB, Enloe CJ, Bodnar K, Birnbaum HG, Holly P, Ben-Joseph R. The Burden of Undiagnosed Opioid Abuse Among Commercially Insured Individuals. Pain Medicine (Malden, Mass.). 16: 1325-32. PMID 25929289 DOI: 10.1111/pme.12768  0.779
2015 Shei A, Rice JB, Kirson NY, Bodnar K, Birnbaum HG, Holly P, Ben-Joseph R. Sources of prescription opioids among diagnosed opioid abusers. Current Medical Research and Opinion. 31: 779-84. PMID 25661018 DOI: 10.1185/03007995.2015.1016607  0.77
2014 Kirson NY, Shei A, Birnbaum HG, Ben-Joseph R, Michna E. Medical resource use and costs among pain patients with potential opioid-tolerability issues. Journal of Opioid Management. 10: 305-10. PMID 25350472 DOI: 10.5055/jom.2014.0220  0.698
2014 Rice JB, Kirson NY, Shei A, Enloe CJ, Cummings AK, Birnbaum HG, Holly P, Ben-Joseph R. The economic burden of diagnosed opioid abuse among commercially insured individuals. Postgraduate Medicine. 126: 53-8. PMID 25141243 DOI: 10.3810/pgm.2014.07.2783  0.786
2014 Kirson NY, Shei A, White AG, Birnbaum HG, Ben-Joseph R, Rossiter LF, Michna E. Societal economic benefits associated with an extended-release opioid with abuse-deterrent technology in the United States. Pain Medicine (Malden, Mass.). 15: 1450-4. PMID 25041231 DOI: 10.1111/pme.12489  0.708
2014 Rice JB, Kirson NY, Shei A, Cummings AK, Bodnar K, Birnbaum HG, Ben-Joseph R. Estimating the costs of opioid abuse and dependence from an employer perspective: a retrospective analysis using administrative claims data. Applied Health Economics and Health Policy. 12: 435-46. PMID 24919646 DOI: 10.1007/s40258-014-0102-0  0.753
2014 Michna E, Kirson NY, Shei A, Birnbaum HG, Ben-Joseph R. Use of prescription opioids with abuse-deterrent technology to address opioid abuse. Current Medical Research and Opinion. 30: 1589-98. PMID 24738694 DOI: 10.1185/03007995.2014.915803  0.77
2014 Rossiter LF, Kirson NY, Shei A, White AG, Birnbaum HG, Ben-Joseph R, Michna E. Medical cost savings associated with an extended-release opioid with abuse-deterrent technology in the US. Journal of Medical Economics. 17: 279-87. PMID 24559196 DOI: 10.3111/13696998.2014.897628  0.728
Show low-probability matches.